Pharmaceutical Statistics

Cover image for Vol. 14 Issue 2

Editors-in-Chief: Oliver Keene, Thomas Permutt and Gerd Rosenkranz

Impact Factor: 1.102

ISI Journal Citation Reports © Ranking: 2013: 45/119 (Statistics & Probability); 201/256 (Pharmacology & Pharmacy)

Online ISSN: 1539-1612

Recently Published Issues

See all

Pharmaceutical Statistics OnlineOpen

OnlineOpen – The Open Access Option for Authors

OnlineOpen is available to authors who wish to make their article open access, free to read, download and share via Wiley Online Library and PubMed Central. Read this recent OnlineOpen article. Yours can be too. Learn more about OnlineOpen.

Read these recently published OnlineOpen Papers:

Data-driven treatment selection for seamless phase II/III trials incorporating early-outcome data, C. Kunz et al

A review and re-interpretation of a group-sequential approach to sample size re-estimation in two-stage trials, J. Bowden and A. Mander

 Pharmaceutical Statistics OnlineOpen

Welcome to the new Editor-in-Chief

We are delighted to welcome Tom Permutt as one of three Editors-in-Chief of Pharmaceutical Statistics.

Tom Permutt supervises the statisticians at FDA working on analgesic, pulmonary, and endocrine drugs. He was among the first to apply methods of causal inference, which he had learned by way of econometrics, to questions in biostatistics. He has been interested in the missing data problem since 1975, when he spent a summer at the Census Bureau phoning farmers who hadn’t filled out their census forms.

Tom joins existing editors Oliver Keene and Gerd Rosenkranz in the role.

PSI's Pharmaceutical Statistics Journal Club

The most recent Journal Club, sponsored by Wiley, covered HTA and Safety Analyses. The event took place on 25th November 2014 with two speakers presenting their papers, David Ohlssen (Novartis Pharmaceuticals Corporation) and Christine Fletcher (Amgen Ltd).

Speaker: David Ohlssen, Novartis Pharmaceuticals Corporation
Guidance on the implementation and reporting of a drug safety Bayesian network meta-analysis
Pharmaceutical Statistics, Volume 13, Issue 1, January/February 2014

Speaker: Christine Fletcher, Amgen Ltd
Subgroup analyses in cost-effectiveness analyses to support health technology assessments
Pharmaceutical Statistics, Volume 13, Issue 4, July/August 2014

Full details are available at

Archive of previous Journal Club meetings